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A B S T R A C T
Purpose: Abnormal cortical plasticity has been hypothesized to play a crucial role in the pathogenesis of
juvenile myoclonic epilepsy (JME). To study the motor cortical plasticity we used paired associative
stimulation (PAS). When a repetitive electrical stimulus to the median nerve is paired with a transcranial
magnetic stimulus (TMS) pulse over the controlateral motor cortex with at an interstimulus interval (ISI)
of 21.5–25 ms, a long term potentiation (LTP)-like synaptic plasticity is induced in the corticospinal
system.
Aim of this study was to investigate the motor cortex LTP-like synaptic plasticity by means of PAS in
patients with JME.
Methods: Twelve adult patients with JME were compared with 13 healthy subjects of similar age and
sex. PAS consisted of 180 electrical stimuli of the right median nerve paired with a single TMS over the
hotspot of right abductor pollicis brevis (APB) at an ISI of 25 ms (PAS25). We measured motor evoked
potentials (MEPs) before and after each intervention for up to 30 min.
Results: In healthy subjects the PAS25 protocol was followed by a signiﬁcant increase of the MEP
amplitude (p < 0.001). On the contrary, in patients with JME, the MEP amplitude did not change.
Conclusion: Defective motor cortex plasticity is likely involved in the pathogenesis of JME.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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Juvenile myoclonic epilepsy (JME) is the most common idiopathic
generalized epilepsy (IGE), with a presumed genetic aetiology
[1]. Myoclonic jerks, absences and generalized tonic–clonic seizures
are the core ﬁndings in this syndrome [2]. So far, motor cortex
hyperexcitability [3] and abnormal function of fronto-thalamic
networks have been involved in the pathophysiology of JME [4–
6]. Hyperexcitability of primary visual areas and excessive response
of the primary motor cortex to visual inputs would be another
important factor [7,8] since the presence of a photoparoxysmal
response is common [2].
Abnormal cortical plasticity has been frequently hypothesized
to play a crucial role in the pathogenesis of epilepsies [9,10], at
least in experimental models of temporal lobe epilepsy [11]. How-
ever, considering the clinical context, there are no direct evidences
to support this hypothesis, possibly because of experimental* Corresponding author at: Department of Translational Medicine, Section of
Neurology, University of Piemonte Orientale ‘‘A. Avogadro’’, Via Solaroli 17, 28100
Novara, Italy. Tel.: +39 03213733767.
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1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights redifﬁculties. Transcranial magnetic stimulation (TMS) is a well-
established, safe, painless and non-expensive neurophysiologic
method for non-invasive measurement of cortical excitability
[12]. It also offers a unique opportunity to study cortical plasticity
in a non-invasive fashion. In the last few years, a variety of TMS
protocols have been developed to probe mechanisms of synaptic
plasticity in the intact human brain [13]. Among these, paired
associative stimulation (PAS) involves repeated pairing of an
electrical stimulus to the median nerve with a later transcranial
magnetic stimulus (TMS) over the contralateral motor cortex
[14,15]. This induces changes in cortical excitability, whose sign
depends on the interval between the median nerve and the TMS
stimuli. Intervals of 25 ms (PAS25) have an enhancing effect, whereas
intervals of around 10 ms (PAS10) reduce excitability [14–16]. Phar-
macological studies suggest that such changes involve temporary
modiﬁcations in synaptic efﬁcacy, equivalent to long-term potentia-
tion (LTP) and long-term depression (LTD), as described in animal
preparations [17].
Aim of the present study was to test the effects of PAS25 in
patients with JME compared to healthy controls. We wanted to
explore if, in the complex framework of the JME pathophysiology, an
abnormal motor cortical plasticity could play a given role.served.
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2.1. Subjects
We studied 12 consecutive adult patients with JME (10 female,
mean age 32.8 years, SD 10.7) referring to the Epilepsy Clinic of the
University Department of Neurology, Novara, Italy. Diagnoses were
made by two experienced epileptologists not involved in the
present study on the basis of the clinical history, seizure type and
electroencephalography (EEG) ﬁndings according to the estab-
lished diagnostic criteria [18].
Thirteen normal subjects of similar age and sex acted as
controls (10 female, mean age 27.9 years; SD 5.6). They had no
family or personal history of neurologic disease or epilepsy.
Reportedly, both patients and controls had not been taking
neuroactive drugs (alcohol and caffeine included) for 72 h prior
to the study, except for the patient antiepileptic treatment. Their
general and neurological examinations were normal. All subjects
were right-handed based on the Edinburgh Handedness Inventory
and gave written informed consent. Experiments were approved
by the local Ethics Committee and were performed in accordance
with the Declaration of Helsinki.
2.2. Patient features
The clinical features of patients are reported in Table 1. Eight of
the 12 patients were classiﬁed as photosensitive because they
showed a photoparoxysmal response (PPR) to intermittent light
stimulation (ILS), which did never entail clinical phenomena. ILS
was performed according to the international standards [19]. In
general, the clinical course of the patients was favourable, and all of
them reported being seizure-free. All patients were on a standard
antiepileptic treatment. Valproate, alone or in combination with
levetiracetam, was the most frequent choice.
2.3. TMS and EMG recordings
All neurophysiologic studies took place between 2:00 and 6:30
p.m. in a quiet laboratory, at a standard temperature of 22 8C.
Subjects sat comfortably in a chair with both arms resting on a
pillow placed on their lap. Motor-evoked potentials (MEPs) were
recorded from the abductor pollicis brevis (APB) muscle using
9 mm-diameter Ag–AgCl surface-cup electrodes, in a typical belly-
tendon montage. Data were collected, ampliﬁed (gain, 1000), and
ﬁltered (20 Hz to 3 kHz) through a CED 1902 isolated ampliﬁer
(CED, Cambridge, UK) that fed signals to an A/D converter (CED
Micro 1401 Mk II). The sampling rate was 10 kHz. The signal was
then recorded by a PC using Signal software ver. 4.08 (Cambridge
Electronic Devices, Cambridge, UK).Table 1
Main clinical features of patients.
Patient # Age Sex Current treatment (mg/die) Photosensitivity
1 26 F 400 LTG Yes
2 48 F 1300 VPA + 1000 LEV Yes
3 22 F 100 LTG Yes
4 49 F 800 VPA No
5 45 F 800 VPA No
6 25 M 900 VPA No
7 42 F 1000 VPA + 100 PB Yes
8 24 F 400 LTG Yes
9 28 M 300 VPA Yes
10 26 F 1000 LEV Yes
11 38 F 115 PB Yes
12 21 F 800 VPA No
JME: juvenile myoclonic epilepsy; LEV: levetiracetam; LTG: lamotrigine; PB:
phenobarbital; VPA: valproic acid.TMS was delivered through a Magstim 2002 stimulator
(Magstim) every 4.5–5.5 s. A ﬁgure-of-eight coil (outer winding
diameter 70 mm) was held tangentially on the scalp at an angle of
45 deg to the midsagittal plane with the handle pointing laterally
and posteriorly. Stimuli were applied to the motor cortex
representation of the right APB. The motor hot spot was deﬁned
as the point where a magnetic stimulus of constant, slightly
suprathreshold intensity consistently elicited an MEP of the highest
amplitude. Motor cortex excitability was measured as the peak-to-
peak amplitude of the MEP generated by single pulse TMS.
2.4. Paired associative stimulation (PAS)
PAS consisted of 180 electrical stimuli of the right median nerve
at the wrist paired with a single TMS shock over the hotspot of right
APB muscle at a rate of 0.2 Hz [14,20]. Electrical stimulation
(square wave pulse; stimulus duration, 0.2 ms) was applied at an
intensity of three times the perceptual threshold using a constant
current generator (Digitimer, Welwyn Garden City, UK). TMS was
applied at an intensity required to elicit a 1 mV MEP (SI1mV). The
effects of PAS given with an interstimulus interval of 25 ms
between peripheral and TMS stimuli were tested (PAS25). Subjects
were instructed to look at their stimulated hand and count the
peripheral electrical stimuli they perceived. The MEPs evoked in
the APB were displayed online during the intervention to control
for the correct coil position and stored for off-line analysis.
2.5. Experimental procedures
The resting motor threshold (RMT) and MEP size were
measured. RMT was deﬁned as the lowest intensity that evoked
a response of about 50 mV in the relaxed APB in at least 5 of
10 consecutive trials [21]. The stimulus intensity was changed in
steps of 1% of the maximum stimulator output (MSO). Thirty MEPs
were recorded with a stimulus intensity of SI1mV before (baseline)
and for up to 30 min (T0, T15 and T30) after PAS25. SI1mV was kept
constant throughout the experiment. The mean peak-to-peak
amplitude was calculated for the data obtained before and after
PAS in each single subject.
2.6. Data analysis
The baseline physiological parameters are given in Table 2. The
between-group comparability of these variables was tested by a
Student’s paired t test (two-tailed).
MEP amplitudes at each time point were averaged and
normalized to baseline. Then they entered a two-way repeated
measures (rm) ANOVA with factors ‘‘GROUP’’ (patients, controls)
and ‘‘TIME’’ (T0, T15 and T30). In order to evaluate the effects of PAS
in each group, a one-way ANOVA was employed with a main factor
of ‘‘TIME’’ (baseline, T0, T15 and T30), using absolute MEP values in
each experimental session. The Greenhouse–Geisser correctionTable 2
Physiological data (mean  SEM).
HS JME Differences
among groups
# 13 12
Age 27.9  1.5 32.8  3.1 n.s.
Sex (female) 10 10 n.s.
RMT (%) 40.2  1.0 44.7  2.5 n.s.
PsT (mA) 2.2  0.2 2.6  0.2 n.s.
SI1mV (%) 51.8  2.5 55.3  3.2 n.s.
Baseline MEP (mV) 0.94  0.07 1.08  0.08 n.s.
HS: healthy subjects; JME: juvenile myoclonic epilepsy patients; MEP: motor
evoked potential; psT: peripheral sensory threshold; RMT: resting motor threshold;
SI1mV: intensity required to elicit a 1 mV MEP; n.s.: non-signiﬁcant.
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were considered signiﬁcant. Bonferroni’s post hoc tests or paired
t tests (two-tailed) were used for further analyses. Data were
analyzed using software (SPSS v. 19.0 for Windows; SPSS Inc.). All
data are given as mean  standard error of the mean (SEM).
3. Results
The procedure was well tolerated and no subjects experienced
adverse events or seizures during and after the experimental
session. Baseline physiological measures and p values are shown in
Table 2. In brief, no signiﬁcant differences in the RMT and baseline
MEP amplitude were detected between the two groups.
A preliminary two-way rmANOVA on normalized to baseline
values revealed a signiﬁcant effect of GROUP (F (1, 23) = 14.244,
p = 0.001) but no effects of TIME (F (2, 46) = 0.251, p = 0.779) nor a
GROUP  TIME interaction (F (2, 46) = 0.157, p = 0.855). Post hoc
paired t tests revealed signiﬁcant group differences at T0
(p = 0.001), T15 (p = 0.003) and T30 (p = 0.013) (Fig. 1).
One-way ANOVAs separately showed that following PAS25, MEP
sizes were signiﬁcantly increased at T0, T15 and T30 compared to
baseline MEP values (effects of ‘TIME’, F (3, 36) = 10.315, p < 0.001)
in the control group but not in the patients (effects of ‘TIME’, F (3,
33) = 0.158, p = 0.924). Post hoc analysis with Bonferroni’s correc-
tion showed a signiﬁcant increase of MEP sizes compared with
baseline at T0 (p < 0.001), T15 (p = 0.003) and T30 (p < 0.001).
4. Discussion
As in the case of ours, the PAS protocol is usually followed – in
healthy subjects – by a sustained increase of the MEP size.
Admittedly this represents a LTP-like plasticity phenomenon
[14]. On the contrary, in our JME patients, the MEP amplitude did
not change, suggesting that LTP-plasticity may be deﬁnitely
altered in this disease.
PAS is thought to explore the motor cortex synaptic plasticity
[14,20,22], that is the ability of neurons to change the efﬁcacy of
their synaptic transmission [23]. A long-lasting enhancement is
called LTP, and it has been involved in motor learning [24–27]
whereas its impairment is crucial in the pathophysiology of a
number of movement disorders [28–30]. In contrast, in patients
with epilepsy, studies with LTP-like plasticity protocols were very
limited so far, possibly because epilepsy itself represents a relative
contraindication to TMS, due to the theoretical risk of seizure
induction. However, this is a rare event, associated with a crude risk
of 1.4% [31] and accordingly, the most recent guidelines considered
repetitive TMS safe in this context [32]. On the contrary, LTD-like
plasticity protocols, i.e. low-frequency repetitive TMS, have been
frequently applied for therapeutic purposes [32,33].Fig. 1. Grand average of normalized MEPs at T0, T15 and T30 to baseline in patients
(black) and controls (white). Asterisks indicate a signiﬁcant difference (p < 0.05).We studied patients with JME because the primary motor
cortex is both involved in the pathophysiology of cortical
myoclonus [2] and the most accessible cortical area to TMS
[12]. Furthermore, when the motor cortex is not directly involved,
it can be inﬂuenced at a distance by non-motor epileptogenic areas
[34]. Admittedly, a number of excitability measures have already
been studied in patients with JME [12]. Overall, the most consistent
ﬁnding is related to short-interval intracortical inhibition (SICI)
substantially reduced in patients with JME compared to healthy
controls [35–37] and further decreased after sleep deprivation
[38]. SICI reduction is thought to reﬂect a defective gabaergic
inhibition in the motor cortex and particularly of GABAA receptor-
mediated effects [12,39]. Besides, the PAS protocol was ﬁrst
applied in a recent study on a small cohort of patients with
Unverricht–Lundborg disease, i.e. the most common form of
progressive myoclonic epilepsy (PME). The response to PAS25 was
found defective, which was interpreted as disturbed motor cortical
functions underlying the motor symptoms [40]. Interestingly, our
results are in line with these ﬁndings and highlight the importance
of abnormal motor cortical excitability in both PME and JME,
although the underlying pathophysiology is most likely different
[37].
We suggest three possible mechanisms involved in the
disruption of the motor cortical plasticity in patients with JME:
(1) A pathological form of plasticity may occur during epilepto-
genesis leading into an unbalance between excitatory and
inhibitory neural circuits in speciﬁc networks, i.e. the motor
cortex [41]. In fact, a close relation between LTP and epileptogen-
esis was recently demonstrated in models of hippocampal epilepsy
[10]. Additionally, kindling protocols trigger a large number of
effects, some of which appear similar to LTP [42]. In this view,
abnormal cortical plasticity may be the neurophysiological
background for the development of myoclonus both in JME and
PME [40]. (2) Seizures themselves have a signiﬁcant and lasting
impact on the brain in animal models of epilepsy [10], leading to
structural and functional alterations of neuronal circuits which
may be accompanied by declining cognitive and behavioural
functions [9], as already recognized in JME [43]. The background of
these manifestations might include an impairment of cortical
plasticity. (3) The antiepileptic treatment itself may induce long
lasting changes in cortical plasticity. Indeed, AEDs may affect
cortical excitability [39] and recent evidences suggest that a single
dose of lamotrigine [44] and levetiracetam [45] resulted in a
signiﬁcant reduction of the LTP-like MEP increase in healthy
subjects. It has been suggested that this action may contribute to
its antiepileptic effects and a successful antiepileptic treatment
may have to reduce plasticity to be effective [45].
Any combination of these mechanisms might be possible,
although we favour the hypothesis on the role of a defective
plasticity as the background for the development of the motor
features in JME (and PME) such as the epileptic myoclonus. Indeed,
the motor cortex hereby studied is one of the fundamental
elements of a complex fronto-thalamic network [4–6] which is
affected by multi-focal disease mechanisms in JME [46] and
possibly explains the peculiar seizure types, i.e. myoclonic jerks
and absences [6]. Besides, motor cortex itself is part of a visuo-
motor network [47] which is most likely involved in the
pathophysiology of the common PPR [7,8].
Pharmacological manipulation of PAS-induced LTP-like plastic-
ity in healthy volunteers revealed suppressive effects of the
antagonists of major neuromodulatory neurotransmitters dopa-
mine, norepinephrine and acetylcholine [48]. Of these, the
dopaminergic signalling appears of greater importance because
it is necessary for normal motor skill learning and synaptic
plasticity within the primary motor cortex of animal models
[49]. Interestingly, a speciﬁc alteration of the dopaminergic system
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patients [51–53] has been revealed with positron emission
tomography (PET). Additionally, dopamine itself is neuroprotec-
tive and have inhibitory properties on seizures [54,55], particularly
myoclonic seizures [56]. Therefore, we speculate that the
disruption of motor cortical plasticity in patients with JME may
be the neurophysiological counterpart of a defective dopaminergic
signalling. Further studies correlating dopaminergic signalling and
TMS measures are needed to corroborate this hypothesis.
This study has few limitations. First, the sample size is small and
general conclusions should be inferred with caution. It prevented
useful correlations with the clinical features. Secondly, a control
group of drug naı¨ve patients with myoclonic seizures would have
possibly disentangled the confounding role of AEDs on cortical
plasticity. However, ethical constraints hindered the recruitment
of these patients.
5. Conclusions
The present data provide evidence of a defective LTP-like
plasticity in a cohort of patients with JME, which may be primarily
involved in the pathogenesis of myoclonus in this frequent form of
epilepsy.
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